Liver resection for hepatocellular carcinoma in patients with hematological malignancies

BACKGROUND: Improvements in antimetabolite drugs have prolonged the survival of patient with hematological malignancies. However, these drugs may have hepatotoxic side effects and may induce acute liver failure, chronic liver fibrosis, cirrhosis, or even hepatocellular carcinoma (HCC). Although live...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hui-Chen, Yang, Yang-Shen, Teng, Chieh-Lin Jerry, Shen, Ching-Hui, Jan, Yee-Gee, Cheng, Shao-Bin, Wu, Cheng-Chung, Lin, Yi-Ling, Huang, Chu-Chun, P’eng, Fang-Ku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667519/
https://www.ncbi.nlm.nih.gov/pubmed/29096656
http://dx.doi.org/10.1186/s12957-017-1260-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667519/
https://www.ncbi.nlm.nih.gov/pubmed/29096656
http://dx.doi.org/10.1186/s12957-017-1260-y

Ejemplares similares